Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays.

Owain Thomas, Emanuel Lybeck, Karin Strandberg, Nahreen Tynngård, Ulf Schött

Research output: Contribution to journalArticlepeer-review

500 Downloads (Pure)

Abstract

Low molecular weight heparins (LMWH's) are used to prevent and treat thrombosis. Tests for monitoring LMWH's include anti-factor Xa (anti-FXa), activated partial thromboplastin time (aPTT) and thrombin generation. Anti-FXa is the current gold standard despite LMWH's varying affinities for FXa and thrombin.
Original languageEnglish
Article numbere0116835
JournalPLoS ONE
Volume10
Issue number1
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Anesthesiology and Intensive Care
  • Hematology
  • Medicinal Chemistry

Fingerprint

Dive into the research topics of 'Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays.'. Together they form a unique fingerprint.

Cite this